Table 5

Sensitivity of the EFNS/PNS and EAN/PNS criteria in typical CIDP and its variants

EFNS/PNS electrodiagnostic criteria for possible CIDPEFNS/PNS electrodiagnostic criteria for probable/definite CIDPEFNS/PNS criteria for probable/definite CIDP using supportive criteriaEAN/PNS electrodiagnostic criteria for possible CIDPEAN/PNS electrodiagnostic criteria for CIDPEAN/PNS criteria for CIDP using supportive criteriaP value
Typical CIDP, n (%)232/251 (92%)217/251 (86%)229/251 (91%)158/195 (81%)149/195 (76%)153/195 (78%)<0.001*, †, ‡
DADS/distal CIDP, n (%)24/29 (83%)22/29 (76%)24/29 (83%)35/41 (85%)29/41 (71%)31/41 (76%)
LSS/multifocal CIDP and focal CIDP, n (%)17/19 (89%)17/19 (89%)17/19 (89%)17/23 (74%)14/23 (61%)16/23 (70%)
Sensory CIDP, n (%)13/14 (93%)10/14 (71%)12/14 (86%)27/31 (87%)§
21/31 (68%) ¶
22/31 (71%)
Motor CIDP, n (%)17/17 (100%)16/17 (94%)17/17 (100%)17/17 (100%)14/17 (83%)15/17 (88%)
  • *EFNS/PNS electrodiagnostic criteria for possible CIDP versus EAN/PNS electrodiagnostic criteria for possible CIDP.

  • †EFNS/PNS electrodiagnostic criteria for probable/definite CIDP versus EAN/PNS electrodiagnostic criteria for CIDP.

  • ‡EFNS/PNS criteria for probable/definite CIDP using supportive criteria versus EAN/PNS criteria for CIDP using supportive criteria.

  • §Patients with electrodiagnostic testing of sensory CIDP and sensory predominant CIDP/clinical diagnosis of sensory CIDP.

  • ¶Patients with electrodiagnostic testing of sensory predominant CIDP/clinical diagnosis of sensory CIDP.

  • CIDP, chronic inflammatory demyelinating polyradiculoneuropathy; DADS, distal acquired demyelinating symmetric neuropathy; EAN/PNS, european academy of neurology/peripheral nerve society; EFNS/PNS, european federation of neurological societies/peripheral nerve society; LSS, lewis-sumner syndrome; N, number.